HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Lin Selected Research

Craniofacial Dysostosis (Crouzon Disease)

11/2017FGFR2 mutations and associated clinical observations in two Chinese patients with Crouzon syndrome.
9/2016Molecular analysis of FGFR 2 and associated clinical observations in two Chinese families with Crouzon syndrome.
1/2012FGFR2 molecular analysis and related clinical findings in one Chinese family with Crouzon syndrome.
1/2012Ala344Pro mutation in the FGFR2 gene and related clinical findings in one Chinese family with Crouzon syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Lin Research Topics

Disease

100Neoplasms (Cancer)
04/2022 - 05/2002
64Breast Neoplasms (Breast Cancer)
06/2022 - 07/2002
29Neoplasm Metastasis (Metastasis)
01/2022 - 01/2004
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2002
11Inflammation (Inflammations)
01/2022 - 06/2005
10Carcinogenesis
01/2022 - 12/2002
10Triple Negative Breast Neoplasms
01/2022 - 01/2017
9Infections
12/2019 - 06/2005
8Stomach Neoplasms (Stomach Cancer)
01/2021 - 12/2015
7Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2018
7Cataract (Cataracts)
01/2021 - 02/2008
7Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 09/2009
7Lung Neoplasms (Lung Cancer)
01/2020 - 03/2003
6Hearing Loss (Hearing Impairment)
01/2022 - 01/2011
6Hypoxia (Hypoxemia)
01/2021 - 02/2009
6Insulin Resistance
07/2020 - 08/2002
5Multiple Myeloma
01/2021 - 01/2018
5Body Weight (Weight, Body)
10/2020 - 04/2014
5Leukemia
09/2020 - 03/2013
5Hyperglycemia
10/2019 - 08/2002
5Carcinoma (Carcinomatosis)
01/2019 - 01/2014
5Myopia
01/2018 - 06/2011
4Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 07/2002
4Disease Progression
06/2022 - 10/2019
4Weight Gain
06/2022 - 10/2012
4Congenital Abnormalities (Deformity)
03/2022 - 01/2019
4Trisomy (Trisomies)
01/2022 - 01/2018
4Pain (Aches)
11/2021 - 03/2007
4Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2004
4Renal Cell Carcinoma (Grawitz Tumor)
11/2020 - 08/2012
4Hemorrhage
01/2020 - 01/2018
4Hepatocellular Carcinoma (Hepatoma)
01/2020 - 09/2012
4Thrombosis (Thrombus)
06/2019 - 06/2007
4Ischemia
01/2018 - 03/2003
4Craniofacial Dysostosis (Crouzon Disease)
11/2017 - 01/2012
4Postmenopausal Osteoporosis
03/2016 - 04/2014
4Osteoporosis
03/2016 - 04/2014
3Weight Loss (Weight Reduction)
06/2022 - 01/2020
3Coronary Artery Disease (Coronary Atherosclerosis)
05/2022 - 01/2020
3Dyslipidemias (Dyslipidemia)
04/2022 - 12/2017
3Congenital Heart Defects (Congenital Heart Defect)
03/2022 - 08/2009
3Wounds and Injuries (Trauma)
09/2021 - 08/2014
3Adenocarcinoma of Lung
08/2021 - 05/2006
3Pneumonia (Pneumonitis)
03/2021 - 04/2011
3Sepsis (Septicemia)
02/2021 - 11/2010

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2002
24Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2003
15CytokinesIBA
01/2021 - 05/2002
14Messenger RNA (mRNA)IBA
08/2022 - 03/2003
14Estrogen ReceptorsIBA
09/2021 - 04/2004
13MicroRNAs (MicroRNA)IBA
04/2022 - 03/2009
13Pharmaceutical PreparationsIBA
01/2022 - 03/2007
13Biological ProductsIBA
01/2022 - 10/2007
12Interleukin-8 (Interleukin 8)IBA
01/2020 - 03/2004
11Retinaldehyde (Retinal)IBA
01/2021 - 01/2010
9Glucose (Dextrose)FDA LinkGeneric
01/2021 - 02/2005
8EnzymesIBA
01/2020 - 07/2008
7Small Interfering RNA (siRNA)IBA
01/2020 - 04/2012
7Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
11/2017 - 01/2012
6Interleukin-6 (Interleukin 6)IBA
02/2021 - 08/2008
6CateninsIBA
01/2021 - 04/2015
6transgelinIBA
01/2020 - 09/2009
6DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2010
5osthol (osthole)IBA
01/2022 - 01/2018
5Hormones (Hormone)IBA
01/2022 - 01/2006
5RNA (Ribonucleic Acid)IBA
01/2022 - 12/2017
5Insulin (Novolin)FDA Link
07/2020 - 02/2010
5LipidsIBA
07/2020 - 12/2017
5Transcription Factors (Transcription Factor)IBA
01/2020 - 08/2002
5AntigensIBA
08/2017 - 07/2008
5ORALIT (ORS)IBA
01/2017 - 11/2011
5Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2012 - 12/2002
4Indicators and Reagents (Reagents)IBA
06/2022 - 01/2017
4human ERBB2 proteinIBA
03/2022 - 01/2019
4Docetaxel (Taxotere)FDA Link
01/2022 - 02/2013
4TamoxifenFDA LinkGeneric
09/2021 - 09/2014
4Long Noncoding RNAIBA
01/2021 - 01/2015
4MethyltransferasesIBA
09/2020 - 12/2014
4Histones (Histone)IBA
03/2020 - 01/2017
4AcidsIBA
01/2020 - 01/2014
4InterferonsIBA
12/2019 - 01/2011
4Dinoprostone (PGE2)FDA Link
01/2019 - 12/2002
3Capecitabine (Xeloda)FDA Link
03/2022 - 01/2021
3Trastuzumab (Herceptin)FDA Link
03/2022 - 01/2021
3Phosphotransferases (Kinase)IBA
01/2022 - 01/2013
3N-(4-isothiocyanatophenethyl)spiperoneIBA
01/2022 - 11/2019
3Circular RNAIBA
10/2021 - 01/2021

Therapy/Procedure

40Therapeutics
06/2022 - 10/2007
17Drug Therapy (Chemotherapy)
01/2022 - 03/2011
6Immunotherapy
01/2022 - 03/2013
5Adjuvant Chemotherapy
11/2021 - 06/2012
5Ligation
02/2021 - 11/2007
5Electroacupuncture
01/2021 - 04/2014
4Lasers (Laser)
10/2022 - 08/2010
4Secondary Prevention
05/2022 - 08/2019
4Vitrectomy
01/2022 - 05/2012
4Acupuncture Points (Acupuncture Point)
11/2021 - 02/2010
4Transplantation
02/2017 - 01/2013
3Neoadjuvant Therapy
01/2022 - 01/2021
3Aftercare (After-Treatment)
11/2021 - 04/2011